Gene Olinger
Overview
Explore the profile of Gene Olinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yeh K, Parekh F, Mombo I, Leimer J, Hewson R, Olinger G, et al.
Front Public Health
. 2023 Feb;
11:1018293.
PMID: 36741948
Climate change impacts global ecosystems at the interface of infectious disease agents and hosts and vectors for animals, humans, and plants. The climate is changing, and the impacts are complex,...
2.
Armstrong D, Tacheny E, Olinger G, Howard R, Lemmon M, Dasgupta D, et al.
J Clin Microbiol
. 2021 Sep;
59(12):e0077821.
PMID: 34586893
The SARS-CoV-2 pandemic has strained manufacturing capacity worldwide, resulting in significant shortages of laboratory supplies both directly and indirectly. Such shortages include probe-based kits for detection of the Mycobacterium tuberculosis...
3.
Yeh K, Tabynov K, Parekh F, Mombo I, Parker K, Tabynov K, et al.
Front Bioeng Biotechnol
. 2021 Sep;
9:720315.
PMID: 34485259
High containment biological laboratories (HCBL) are required for work on Risk Group 3 and 4 agents across the spectrum of basic, applied, and translational research. These laboratories include biosafety level...
4.
Yeh K, Scullion M, Michelotti J, Olinger G
Front Med (Lausanne)
. 2021 Apr;
8:639440.
PMID: 33842501
The current unprecedented COVID-19 pandemic underscores the importance of diagnostic assays in health security preparedness and readiness. Advancing new technologies for rapid molecular detection of high consequence infectious pathogens is...
5.
Boudjelal M, Almajed F, Salman A, Alharbi N, Colangelo M, Michelotti J, et al.
Int J Infect Dis
. 2021 Mar;
105:448-451.
PMID: 33652065
The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was a vital event as it provided a hub for leading...
6.
Parekh F, Yeh K, Olinger G, Ribeiro F
Vector Borne Zoonotic Dis
. 2020 Jan;
20(5):387-389.
PMID: 31944914
In January 2019, the state of Minas Gerais experienced another environmental disaster with the collapse of a mining dam near the city of Brumadinho. This disaster has resulted in 256...
7.
Katawera V, Kohar H, Mahmoud N, Raftery P, Wasunna C, Humrighouse B, et al.
Pan Afr Med J
. 2019 Aug;
33(Suppl 2):8.
PMID: 31404295
Introduction: Following a declaration by the World Health Organization that Liberia had successfully interrupted Ebola virus transmission on May 9th, 2015; the country entered a period of enhanced surveillance. The...
8.
Connor J, Kobinger G, Olinger G
Curr Top Microbiol Immunol
. 2017 Jun;
411:263-290.
PMID: 28653190
Therapies for filovirus infections are urgently needed. The paradoxical issue facing therapies is the need for rigorous safety and efficacy testing, adhering to the principle tenant of medicine to do...
9.
Lennemann N, Herbert A, Brouillette R, Rhein B, Bakken R, Perschbacher K, et al.
J Virol
. 2017 Jun;
91(17).
PMID: 28615211
The recent Ebola virus (EBOV) epidemic in West Africa demonstrates the potential for a significant public health burden caused by filoviral infections. No vaccine or antiviral is currently FDA approved....
10.
Wang L, Shi W, Joyce M, Modjarrad K, Zhang Y, Leung K, et al.
Nat Commun
. 2015 Jul;
6:7712.
PMID: 26218507
The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) as a cause of severe respiratory disease highlights the need for effective approaches to CoV vaccine development. Efforts focused solely on...